Two Different Heart Drugs May Work Equally Well for High-Risk Patients, Nagoya University Graduate School of Medicine Study

Published: Apr 06, 2011

TUESDAY, April 5 (HealthDay News) -- People with high blood pressure and impaired glucose tolerance seem to fare equally well when given two separate types of heart drugs, new research suggests. Although an angiotensin II receptor blocker (ARB) and a calcium channel blocker were both effective in this patient population, one difference did emerge, according to a presentation given Tuesday at the annual meeting of the American College of Cardiology in New Orleans: People taking Diovan (valsartan), an ARB, had a lower incidence of being hospitalized for congestive heart failure.

Back to news